Tags : ReDS Technology

Bayer Signs a License Agreement with Sensible Medical for its

Shots: Bayer will utilize Sensible’s ReDS technology as a biomarker for monitoring lung congestion in a clinical study for patients with heart failure, making Bayer, Sensible’s largest customer in Europe The ReDS System is used as Point-of-Care device/marker of lung fluid, producing a Continuum of Care for patients with fluid management problems + HF/ recovering […]Read More